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Abstract
Background:  Eosinophilic  esophagitis  (EoE)  is  characterized  by  eosinophilic  inﬁltration  of  the
esophagus and  is  a  potential  cause  of  dysphagia  and  food  impaction,  most  commonly  affecting
young men.  Esophageal  manometry  ﬁndings  vary  from  normal  motility  to  aperistalsis,  simul-
taneous contractions,  diffuse  esophageal  spasm,  nutcracker  esophagus  or  hypotonic  lower
esophageal  sphincter  (LES).  It  remains  unclear  whether  esophageal  dysmotility  plays  a  signiﬁ-
cant role  in  the  clinical  symptoms  of  EoE.
Aim:  Our  aim  is  to  review  the  pathogenesis,  diagnosis,  and  effect  of  treatment  on  esophageal
dysmotility  in  EoE.
Methods:  A  literature  search  utilizing  the  PubMed  database  was  performed  using  keywords:
eosinophilic  esophagitis,  esophageal  dysmotility,  motility,  manometry,  impedance  planimetry,
barium esophagogram,  endoscopic  ultrasound,  and  dysphagia.
Results:  Fifteen  studies,  totaling  387  patients  with  eosinophilic  esophagitis  were  identiﬁed  as
keeping in  accordance  with  the  aim  of  this  study  and  included  in  this  review.  The  occurrence  of
abnormal esophageal  manometry  was  reported  to  be  between  4  and  87%  among  patients  with
EoE. Esophageal  motility  studies  have  shown  reduced  distensibilty,  abnormal  peristalsis,  and
hypotonicity  of  the  LES  in  patients  with  EoE,  which  may  also  mimic  other  esophageal  motility
disorders  such  as  achalasia  or  nutcracker  esophagus.  Studies  have  shown  conﬂicting  results
regarding  the  presence  of  esophageal  dysmotility  and  symptoms  with  some  reports  suggesting  a
higher rate  of  food  impaction,  while  others  report  no  correlation  between  motor  function  and
dysphagia.
Conclusions:  Motility  dysfunction  of  the  esophagus  in  EoE  has  not  been  well  reported  in  the
literature  and  studies  have  reported  conﬂicting  evidence  regarding  the  clinical  signiﬁcance
of dysmotility  seen  in  EoE.  The  correlation  between  esophageal  dysmotility  and  symptoms  of
 Please cite this article as: Weiss AH, Iorio N, Schey R. La motilidad esofágica en la esofagitis eosinofílica. Revista de Gastroenterología
de México. 2015;80:205--213.
∗ Corresponding author. Section of Gastroenterology Temple University Hospital, 3401 N. Broad Street, Philadelphia, PA.
Tel.: +215 707 9900; fax: +215 707 2684.
E-mail address: Ron.Schey@tuhs.temple.edu (R. Schey).
2255-534X/© 2015 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
206  A.H.  Weiss  et  al.
EoE  remains  unclear.  Larger  studies  are  needed  to  investigate  the  incidence  of  esophageal
dysmotility,  clinical  implications,  and  effect  of  treatment  on  patients  with  EoE.
© 2015  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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La  motilidad  esofágica  en  la  esofagitis  eosinofílica
Resumen
Antecedentes:  La  esofagitis  eosinofílica  (EE)  se  caracteriza  por  la  inﬁltración  de  eosinoﬁlos  en
el esófago  y  es  una  causa  potencial  de  disfagia  e  impactación  alimentaria  que  en  general  afecta
a jóvenes  adultos.  Los  resultados  obtenidos  con  la  manometría  esofágica  son  variados,  y  se  ha
observado motilidad  normal  y  aperistaltis,  contracciones  simultáneas,  esófago  en  cascanueces  o
esfínter esofágico  inferior  hipotónico.  Aún  no  está  claro  si  la  dismotilidad  esofágica  desempen˜a
un papel  importante  en  los  síntomas  clínicos  de  la  EE.
Objetivo:  Revisar  la  patogenia,  el  diagnóstico  y  el  efecto  del  tratamiento  de  la  dismotilidad
esofágica  en  la  EE.
Métodos:  Se  llevó  a  cabo  una  búsqueda  de  la  bibliografía  médica  en  PubMed  uti-
lizando los  términos  ‘‘esofagitis  eosinofílica’’,  ‘‘dismotilidad  esofágica’’,  ‘‘motilidad’’,
‘‘manometría’’,  ‘‘impedancia  planimétrica’’,  ‘‘esofagograma  con  contraste  de  bario’’,
‘‘ultrasonido  endoscópico’’  y  ‘‘disfagia’’.
Resultados:  Se  identiﬁcaron  15  estudios  que  se  ajustaban  al  objetivo,  que  incluyeron  a
387 pacientes  con  esofagitis  eosinofílica„  y  se  incluyeron  en  esta  revisión.  La  incidencia  de
manometría  esofágica  anormal  reportada  en  los  pacientes  con  EE  fue  del  4  al  87%.  Estudios  de
motilidad  esofágica  han  mostrado  distensibilidad  reducida,  peristaltismo  anormal  e  hipotonici-
dad del  esfínter  esofágico  en  pacientes  con  EE,  que  a  la  vez  pueden  mimetizar  otros  trastornos
de motilidad  esofágica,  como  la  acalasia  o  el  esófago  en  cascanueces.  Los  estudios  han  mostrado
resultados  contradictorios  en  relación  con  la  presencia  de  dismotilidad  esofágica  y  síntomas;
así, hay  reportes  que  sugieren  tasas  elevadas  de  impactación  alimentaria  mientras  que  otros
no muestran  ninguna  relación  directa  entre  la  función  motora  y  la  disfagia.
Conclusiones:  La  disfunción  de  la  motilidad  esofágica  en  EE  no  se  ha  reportado  en  profundidad
en la  bibliografía  y  algunos  estudios  muestran  evidencia  contraria  en  cuanto  a  la  importancia
clínica de  la  dismotilidad  observada  en  la  EE.  La  correlación  entre  la  dismotilidad  esofágica  y  los
síntomas de  EE  permanece  aún  poco  clara.  Se  requieren  estudios  más  amplios  para  investigar  la
incidencia de  la  dismotilidad  esofágica,  sus  implicaciones  clínicas  y  el  efecto  del  tratamiento
en pacientes  con  EE.
© 2015  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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osinophilic  esophagitis  (EoE)  is  a  disease  characterized
y  esophageal  dysfunction  and  histologic  evidence  of
osinophilia  and  inﬂammation  ﬁrst  described  nearly  80  years
go.1 In  1977,  Dobbins  et  al.  described  an  association
ith  atopy  in  a  patient  with  a  history  of  asthma  and  hay
ever  who  presented  with  dysphagia  and  normal  upper  gas-
rointestinal  imaging.2 The  following  year,  Landres  et  al.
eported  a  second  patient  with  an  allergy  to  trimetho-
rim/sulfamethoxazole  and  vigorous  achalasia  found  to  have
arked  eosinophilic  inﬁltration  into  the  submucosa  of  the
sophagus.3 Currently,  more  than  200  cases  have  been
eported  with  a  recent  increase  in  prevalence,  which  may
e  partially  attributed  to  clinical  awareness  of  the  disease.
oE  has  been  described  in  North  American  and  European
l
v
t
iopulations  with  prevalence  varying  from  0.4%  in  an  open
opulation  to  6.5%  in  subjects  with  esophageal  symptoms,
hough  it  is  still  considered  somewhat  more  unusual  in  Latin
merican  populations  with  a  recent  Mexican  study  ﬁnding  a
revalence  of  1.7%  amongst  patients  with  symptoms.4,5
EoE  is  likely  triggered  by  an  immune  response  to  anti-
ens  presented  by  food  ingested  via  the  gastrointestinal
ract  or  particles  inhaled  via  the  respiratory  tract.  The
athophysiologic  mechanisms  that  drive  esophageal  dys-
otility  in  patients  with  EoE  are  not  completely  understood,
lthough  several  theories  have  been  postulated.  These  theo-
ies  are  based  on  the  premise  that  immune  system  activation
eads  to  eosinophilic  inﬁltration  of  the  esophagus  and  acti-
ation  of  cytokine-mediated  pathways,  ultimately  leading
o  remodeling  and  alterations  to  the  epithelial  and  subep-
thelial  tissue  structure  and  the  mechanical  properties  of
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over  an  average  9-month  period.  Ten  controls  underwentEsophageal  motility  in  eosinophilic  esophagitis  
the  esophagus.6 The  changes  in  structural  properties  of  the
esophagus  are  a  result  of  the  eosinophils,  masts  cells,  and
cytokines  produced  by  the  inﬂammatory,  epithelial  and  stro-
mal  cells  of  the  esophagus.7
Eosinophils  are  major  effector  cells  of  tissue  ﬁbrosis
and  remodeling  in  diseases  such  as  asthma,  scleroderma
and  other  ﬁbrotic  disorders.8--10 Eosinophils  release  4 cyto-
toxic  granules  that  can  cause  cell  death  and  tissue  damage
upon  release:  major  basic  protein,  eosinophilic  cationic
protein,  eosinophilic  peroxidase  and  eosinophilic  derived
neurotoxin.11 Cell  destruction  and  turnover  is  thought  to
cause  similar  destruction  in  the  gastrointestinal  tract  to  that
in  other  organ  systems,  i.e.  mucosal  friability  which  results
in  painful  mucosal  tears  and  tissue  remodeling  which  can
lead  to  esophageal  rings  and  strictures.7 Recent  studies  have
found  an  association  between  eosinophilia  and  altered  ﬁbro-
genesis  and  motility  from  biopsy  specimens  of  the  upper,
middle  and  lower  third  of  the  esophagus,  suggesting  that
eosinophils  have  the  same  effects  on  tissue  ﬁbrosis  and
remodeling  in  the  esophagus  as  they  do  in  other  previously
studied  organs.12,13 However,  it  is  important  to  consider  that
sampling  techniques  and  imaging  the  deep  layers  of  the
esophagus  have  limited  precision.14
The  process  of  epithelial  mesenchymal  transformation
(EMT),  in  which  epithelial  cells  lose  their  characteristic
properties  and  transform  into  mesenchymal  cells  has  also
been  implicated  in  the  pathogenesis  of  ﬁbrosis  seen  in
EoE.15,16 Using  immunostaining  for  vimentin  (an  interme-
diate  ﬁlament  protein  expressed  by  mesenchymal  cells)
and  cytokeratins  (proteins  of  keratin  containing  intermedi-
ate  ﬁlaments  expressed  by  epithelial  cells)  in  esophageal
mucosal  biopsies,  Kagalwalla  et  al.  found  evidence  of  EMT
and  reported  a  correlation  between  the  degree  of  EMT  and
the  ﬁbrosis  score.16 They  also  found  a  reduction  in  EMT
after  treatment  with  either  steroid  therapy  or  elemental
and  elimination  diets.16
EoE  affects  males  3  times  more  commonly  than  females
and  the  average  age  at  presentation  is  38  years.1 Clinically,
EoE  presents  as  upper  gastrointestinal  symptoms  such  as
food  impaction,  dysphagia,  or  chest  pain  in  adults  and,  less
commonly,  abdominal  pain,  gastroesophageal  reﬂux  disease
(GERD),  weight  loss  and  diarrhea.1,17 Studies  have  shown
that  food  impaction  requiring  endoscopic  removal  occurs
in  33-54%  of  patients  with  EoE,  and  that  up  to  15%  of  all
patients  undergoing  upper  endoscopy  for  dysphagia  have
EoE.18--20 Although  33-70%  of  all  patients  with  EOE  present
with  dysphagia,  the  precise  mechanism  remains  unclear.21
While  presenting  symptoms  vary  between  patients,  the
dominant  pathophysiologic  features  of  the  disease  involve
luminal  stiffening  and  narrowing  associated  with  esophageal
wall  thickening,  ﬁbrosis  and  stricture.22
Endoscopic  ﬁndings  in  patients  with  EoE  may  include
esophageal  strictures,  narrow  caliber  esophagus,  linear  fur-
rows,  white  plaques  or  exudates,  Schatzki  ring  or  pallor  or
decreased  vasculature.17 Studies  have  reported  abnormal
endoscopic  ﬁndings  in  33-95%  of  patients  with  EoE.19,23--25
Histologically,  EoE  presents  with  eosinophilic  inﬁltration
with  ≥15  eosinophils/high-power  ﬁeld  (hpf).  However,  other
disorders  causing  esophageal  eosinophilia  such  as  GERD,
infectious  or  drug-induced  esophagitis  and  collagen-vascular
disorders,  must  be  exluded.1 Treatment  options  include
dietary  restrictions,  medications  such  as  proton  pump
e
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nhibitors  (PPI),  swallowed  corticosteroids,  leukotriene
eceptor  antagonists,  and  esophageal  dilatation.26 Thus  far,
he  data  regarding  the  effect  of  EoE  on  esophageal  motility
s  inconclusive.  This  review  discusses  the  current  data  on
he  effect  of  EoE  on  esophageal  motility  (table  1).
ethods
he  PubMed  database  was  searched  using  the  follow-
ng  keywords:  ‘‘eosinophilic  esophagitis’’,  ‘‘esophageal
ysmotility’’,  ‘‘motility’’,  ‘‘manometry’’,  ‘‘impedance
lanimetry’’,  ‘‘barium  esophagogram’’,  ‘‘endoscopic  ultra-
ound’’,  and  ‘‘dysphagia’’.  There  was  no  time  limit  and  the
ords  ‘‘AND’’  and  ‘‘OR’’  were  used  as  logical  combining
erms,  enabling  us  to  limit  the  information.  The  original  and
eview  articles  resulting  from  the  search  were  selected  in
ccordance  with  the  main  aim  of  this  study.  Two  reviewers
creened  abstracts  from  the  literature  search  and  included
elevant  studies  of  patients  with  diagnosed  EoE  undergoing
ll  types  of  motility  evaluation.
esults
 number  of  alterations  in  the  biomechanical  properties  of
he  esophagus  have  been  implicated  in  the  motility  dys-
unction  described  in  patients  with  EoE  in  the  absence  of
rue  structural  abnormalities.  These  mechanisms  include
bnormal  peristalsis,  abnormal  duration  and  strength  of
ontraction  in  both  the  circular  and  longitudinal  muscles
f  the  esophagus,  and  changes  to  the  dispensability  of
he  esophageal  wall.  The  changes  to  these  biomechanical
roperties  are  evaluated  using  a  variety  of  techniques,  as
escribed  below.
igh  resolution  impedance  planimetry
wo  prior  studies  have  evaluated  esophageal  distensibility
s  measured  by  high  resolution  impedance  planimetry  and
nvestigated  a  correlation  between  clinical  symptoms  and
ysmotility  in  patients  with  EoE.27--29 Kwiatek  et  al.  included
5  patients  with  EoE  and  previously  documented  symptoms
f  dysphagia,  food  impaction,  chest  pain  or  heartburn.29
hese  were  compared  with  15  control  subjects.  Patients
ere  evaluated  during  endoscopy  using  the  EndoFLIP® probe
Crospon,  Ireland),  which  is  comprised  of  a  compliant  cylin-
rical  bag  with  16  impedance  planimetry  segments.  The  bag
as  distended  in  a  stepwise  fashion  with  intra-bag  pressures
nd  intra-luminal  geometry  measurements  taken  in  the  dis-
al  esophagus.  Authors  found  that  esophageal  distensibility
calculated  as  cross-sectional  area  [CSA]  vs  pressure)  was
ubstantially  reduced  in  EoE  patients  compared  with  con-
rols  (with  median  CSA  267  vs  438  mm2,  p  <  0.01).
Nicoderme  et  al.  evaluated  70  patients  with  EoE  who
nderwent  esophageal  biopsy  and  high  resolution  impedance
lanimetry.27 The  investigators  utilized  a  functional  lumen
maging  probe  and  documented  the  occurrence  of  food
mpaction,  requirement  for  dilation  and  symptom  severityndoscopy  with  biopsy  and  the  EndoFLIP® protocol  for
omparison.  Biopsies  were  obtained  from  the  distal  and  mid-
roximal  esophagus  and  distensibility  was  measured  3  cm
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Table  1  Studies  of  esophageal  motility  in  eosinophilic  esophagus.
Study and design No. of participants Outcomes Study measurement Results Limitations
Korsapati et al.40
P, C
No.= 20; 10 EOE
subjects (4 male; mean
age 28 years) and 10
controls (4 male; mean
age 34 years)
Peristalsis Esophageal
manometry,
endoscopic ultrasound
No difference in peristalsis and
manometric pressures between
controls and EOE subjects.
Decreased changes in muscle
thickness in EOE subjects.
Diminished response of
longitudinal esophageal muscle
in EOE.
Inclusion criteria was ≥
20 eosinophils/hpf;
Bassett et al. 35
P
No.= 32
30 with esophageal
manometry
26 male
Mean age 44 years
Peristalsis, upper and
lower esophageal
sphincter pressures;
symptoms
Esophageal manometry
using
hydropneumocap-illary
perfusion
23 out of 30 subjects had
normal, 6 had low-normal (6-9
mmHg), 1 had low LES pressure
(<5mmHg). LES relaxation was
normal in all. 5 subjects had at
least 30% non-transmitted wet
swallows. No patients with
nutcracker esophagus or DES.
Inclusion criteria was ≥
20 eosinophils/hpf;
military treatment
facility; lack of control
group
Hejazi et al.41
R, CS
No.= 14
13 male
Mean age 35 years
(14-56 yo)
Amplitude of esophageal
contractions, LES pressure
Esophageal
manometry;
pneumohydraulic
capillary infusion (10
subjects); HRM (4
patients)
1  subject with complete
non-peristaltic contractions and
incomplete relaxation of LES; 1
subject with total aperistalsis
and weak LES pressure; 2
subjects with low amplitude
non-peristaltic contractions in
mid-esophagus only; 1 patient
who met  criteria for nutcracker
esophagus; 4 patients with
isolated low LES pressure
Retrospective chart
review
Remedios et al.26
P
No.= 26
≥ 17 years old
13 male, 6 female
completed study
Symptom frequency score,
amplitude peristalsis, LES
pressure. DeMeester score
Barium esophagogram,
esophageal
manometry, 24-hour
ambulatory pH,
endoscopy
22 out of 23 subjects had good
amplitude peristalsis; 10 out of
23 subjects had low LES pressure
which correlated with acid
exposure (8 out of 10 subjects
with acid reﬂex has low LES
pressure)
7  subjects dropped out
of study
Vitellas et al.42
R
No.= 13
All male
Presence of motility
dysfunction
Esophageal manometry 3 out of 13 subjects with motility
disorders: 1 subject with diffuse
esophageal spasm; 1 subject with
increased LES pressure and high
amplitude, prolonged peristalsis;
1 subject with incomplete
relaxation of cricopharyngeus
muscle
Retrospective study, few
subjects
Esophageal
 m
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Table  1  (Continued)
Study and design No. of participants Outcomes Study measurement Results Limitations
Lucendo et al.33
P
No.= 12
11 male; ages 15-59
LES pressure, peristalsis Esophageal manometry
using
hydropneumocapillary
perfusion
10 of 12 subjects had
manometric abnormalities: 6
subjects had up to 80%
interrupted peristalsis or very
low-amplitude peristalsis; 1
subject had primary
simultaneous wave in lower 1/3
esophagus followed by normal
secondary peristaltic wave; 3
subjects had hyperkinetic
peristalsis; slightly low LES
pressure in 2 subjects
Lack of a control group
Nurko et al.43
P
No.=41 (17 with EOE,
13 with GERD,
11 controls)
Mean age 9.7, 13.5,
12.7 respectively
Stationary manometry
and ambulatory PEMP
(20-24 hours)
Abnormal peristalsis in 41% of
EOE subjects on stationary
manometry. PEMP: EOE subjects
had increased isolated (16.7 vs
9.5 vs 6.5; p<0.03) & high
amplitude (4.1 vs 1.8 vs 0.1,
p<0.03) and % ineffective
peristalsis during fasting (70.5%
vs 57.8 vs 53.8, p<.0.05) and
mealtime (68.4% vs 55.3 vs 48.1,
p<0.05) compared to GERD &
controls. 13 patients with EOE
had
21 episodes of dysphagia (all
correlated with simultaneous
abnormal motor function).
Subjects were children
C: controlled; CS: case series; DES: diffuse esophageal spasm; EOE: eosinophilic esophagitis; hpf: high-power ﬁeld; HRM: high-resolution manometry; LES: lower esophageal sphincter; P:
prospective; PEMP: prolonged esophageal manometry and pH-metry; R: retrospective
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c10  
roximal  to  the  esophago-gastric  junction.  The  authors  con-
luded  that  patients  with  prior  food  impactions  or  who  had
ndergone  previous  dilation  had  signiﬁcantly  lower  disten-
ibility  plateau  (DP)  values  (DP  <  225  mm2)  compared  with
hose  who  had  only  solid  food  dysphagia.
Interestingly,  both  studies  reported  that  the  sever-
ty  of  mucosal  eosinophilia,  quantiﬁed  by  the  number  of
osinophils/hpf  did  not  correlate  with  the  risk  of  food
mpaction,  severity  of  dysphagia  or  the  degree  of  esophageal
istensibility.  This  ﬁnding  remained  true  even  in  patients
ho  had  been  treated  with  PPIs;  repeat  biopsies  revealed
ewer  than  15  eosinophils/hpf.27
While  these  studies  suggest  high  resolution  impedance
lanimetry  is  an  effective  tool  to  evaluate  esophageal  dis-
ensibility,  the  lack  of  correlation  between  the  distensibility
urve  proﬁle  and  eosinophilic  density  on  biopsy  or  treat-
ent  with  PPI  with  a  resulting  reduction  in  eosinophil  count
alls  into  question  the  clinical  applicability  of  this  tool.  Most
ikely,  there  are  additional  mechanisms  by  which  eosinophils
ead  to  dysmotility  that  have  not  been  identiﬁed.  If  the
resence  of  poor  esophageal  distensibility  is  a  marker  for
igher  disease  severity,  as  suggested  by  the  authors,  fur-
her  studies  are  required  in  order  to  stratify  ﬁndings  in
atients  with  EoE  who  present  with  less  severe  symptoms
n  order  to  make  a  larger  statement  on  clinical  applica-
ility  of  impedance  planimetry.  These  studies  also  indicate
hat  eosinophil  reduction  on  histopathology  alone  does  not
orrelate  with  clinical  resolution.
arium  esophagogram
ee  et  al.  performed  a  barium  esophagogram  in  11  patients
ith  EoE  before  and  after  6  weeks  of  topical  corticos-
eroid  therapy  to  determine  the  minimum  and  maximum
sophageal  diameters.30 When  compared  with  controls,
atients  with  EoE  had  a  statistically  signiﬁcant  reduction  in
aseline  maximum  esophageal  diameters  (19  mm  in  EOE  vs
4  mm  in  controls,  p  =  0.004).  Median  increases  with  corti-
osteroid  therapy  were  not  statistically  signiﬁcant,  except
n  those  who  had  an  abnormal  baseline  diameter  and  there
as  no  correlation  with  clinical  symptoms  as  documented
y  the  Mayo  Dysphagia  Questionnaire.  The  diameter  mea-
urements  were  reproducible,  but  normal  in  approximately
0%  of  patients  with  EoE.30 Results  suggest  that  those  with
arrowing  may  have  improvement  in  structural  changes  with
teroids;  however  this  may  not  correlate  with  clinical  out-
omes.
Given  that  only  approximately  50%  of  patients  with  EoE
ave  abnormal  baseline  esophageal  diameters  and  statis-
ically  signiﬁcant  changes  in  diameter  had  no  correlation
o  clinical  outcomes,  there  is  currently  no  role  for  bar-
um  esophagogram  in  evaluating  patients  with  eosinophilic
sophagitis.
sophageal  manometry
tudies  using  esophageal  manometry  to  evaluate  patients
ith  EoE  have  produced  inconsistent  results  including
ormal  peristalsis,  aperistalsis,  and  ineffective  peristalsis
econdary  to  simultaneous  contractions  and  high  amplitude
sophageal  body  contractions,  diffuse  esophageal  spasms,
e
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ertiary  contractions,  achalasia,  nutcracker  esophagus,  and
igh  amplitude  contractions  in  the  lower  esophagus.  In  a
eta-analysis  of  77  patients  with  EoE,  Furuta  et  al.  reported
bnormal  esophageal  manometry  in  53%  of  patients  with  30
atients  having  inadequate  peristalsis.1
To  date,  there  have  been  at  least  25  case  reports  or
ublished  series  documenting  the  results  of  esophageal
anometry  in  patients  with  EoE.  In  1993  Attwood  et  al.
eported  the  outcomes  of  12  patients  with  EoE  undergoing
sophageal  manometry.31 Subjects  with  a  high  concentra-
ion  of  intraepithelial  esophageal  eosinophils  on  biopsy
ut  without  anatomic  abnormality  were  included.  Results
evealed  nonspeciﬁc  motility  disturbances  in  10  of  the
2  patients  (83%),  including  diffuse  esophageal  spasm
DES),  nutcracker  esophagus,  mean  amplitude  contractions
ess  than  2.5  percentile  of  normal  and  short  duration
ontraction.  All  patients  had  normal  lower  esophageal
phincter  (LES)  pressure  and  function.31
Lucendo  et  al.  performed  endoscopies  in  patients
ith  EoE  before  and  after  corticosteroid  treatment,  doc-
menting  lower  esophageal  sphincter  dysfunction  and
istal  esophageal  dysfunction  through  manometry  in  73
nd  57%  of  cases,  respectively.32 The  same  authors  also
onducted  a  case  study  of  12  patients  diagnosed  with  EoE
ho  presented  with  dysphagia  or  food  impaction.33 Seven
atients  (58%)  had  abnormalities  on  manometry.  Three
atients  had  hyperkinetic  peristaltic  waves  in  the  distal
hird  of  the  esophagus.  One  patient  had  alteration  in  the
otor  dynamics  with  80%  of  deglutatory  complexes  formed
y  a  simultaneous  ﬁrst  wave  in  the  lower  two  thirds  of  the
sophagus  followed  by  a  second  wave  with  normal  duration
nd  amplitude.  The  LES  tone  was  normal  in  10  patients
nd  reduced  in  2 cases.  In  7  of  9  patients  with  dysmotility,
he  motor  disorder  improved  with  treatment  with  steroid
avage  (using  ﬂuticasone  propionate).33
Monnerat  et  al.  reported  abnormal  esophageal  manom-
try  in  5  of  20  patients  (25%)  with  EoE.34 Motility
bnormalities,  speciﬁcally  low  amplitude  peristaltic  con-
ractions  and/or  non-transmitted  contractions  (n  =  3),
ypertensive  (n  =  1)  and  hypotensive  (n  =  1)  LESs  were
resent  in  40%  (2/5)  of  patients  with  dysphagia  for  solid
oods  and  36%  (4/11)  of  patients  with  recurrent  food
mpaction.
In contrast,  Remedios  et  al.  described  a  case  series  of
6  patients  with  EoE,  all  of  whom  had  a history  of  dys-
hagia  and  11  of  whom  presented  acutely  with  food  bolus
bstruction26. Esophageal  manometry  demonstrated  good
uality  peristalsis  in  22  of  23  patients.  They  reported
educed  LES  pressure  in  10  patients,  however,  this  ﬁnding
orrelated  with  GERD  and  acid  exposure.
Bassett  et  al.  performed  a  prospective  study  and  found
 prevalence  of  non-speciﬁc  esophageal  motility  disorder,
eﬁned  as  ≥  30%  non-transmitted  wet  swallows.35 However,
esults  showed  there  was  no  difference  in  reported  symp-
oms  such  as  swallowing  difﬁculty,  heartburn,  and  chest  pain
n  those  with  non-speciﬁc  esophageal  motility  disorder  and
hose  without.  They  also  found  no  difference  in  eosinophil
ount  on  mucosal  biopsy  between  the  two  groups.In  comparison,  Nurko  et  al.  performed  prolonged
sophageal  manometry  (20-24  hours)  and  found  13  of  17  EoE
atients  experienced  21  episodes  of  dysphagia  and  all
f  these  episodes  corresponded  to  abnormal  esophageal
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motility  (90%  with  non-peristaltic  contractions,  90%  with
isolated  and  repetitive  contractions,  amplitude  >  180  mmHg
in  70%,  abnormal  peaked  contractions  in  41%,  reﬂux  events
<  5  min  in  29.5%,  and  reﬂux  events  >  5  min  in  7%).36
Van  Rhijn  et  al.  compared  esophageal  high  resolution
manometry  measurements  between  31  adults  with  EoE,
31  age  and  sex-matched  GERD  controls,  and  31  healthy
controls.37 These  authors  found  a  higher  frequency  of  failed
(12  vs  6%)  and  weak  (27  vs  15%;  p  <  0.001)  contractions
among  EoE  subjects  than  in  healthy  controls  but  a  similar
occurrence  to  that  of  patients  with  GERD  (failed  14%,  weak
27%).  Importantly,  there  was  no  difference  in  related  symp-
toms  (dysphagia,  heartburn,  limited  food  intake)  or  history
of  food  impaction  between  EoE  patients  with  normal  and
abnormal  motility.  The  prevalence  of  abnormal  motility  was
higher  with  longer  disease  duration  (36%,  0-5  years  vs  83%,
≥  16  years;  p  <  0.05).37
In  a  similar  study,  Roman  et  al.  performed  high  resolu-
tion  manometry  on  48  patients  with  EoE,  48  patients  with
GERD,  and  50  asymptomatic  controls.38 They  found  a  higher
rate  of  motility  disorders  among  patients  with  EoE  compared
with  controls  but  similar  in  prevalence  and  presentation  to
patients  with  GERD.  Both  GERD  and  EoE  subjects  demon-
strated  similar  rates  of  weak  and  failed  peristalsis.  However,
EoE  patients  were  more  likely  than  patients  with  GERD  or
controls  (33%  vs  12%  vs  0%)  to  have  abnormal  bolus  pres-
surization  patterns  during  swallowing;  speciﬁcally,  patients
with  EoE  were  found  to  have  early  pan-esophageal  pres-
surization  (17%  of  patients  with  EoE  vs  2%  of  patients  with
GERD).
This  ﬁnding  is  supported  by  Martin  et  al.,  who  evaluated
21  patients  with  EoE  and  compared  them  to  21  controls  who
had  symptoms  or  GERD  and/or  dysphagia  but  <  5  eosinophils
on  biopsy.39 These  authors  found  that  the  most  frequent
esophageal  motor  abnormality  measured  by  high  resolu-
tion  manometry  was  a  pan-esophageal  pressurization  (48%),
with  a  statistically  signiﬁcant  difference  in  the  prevalence
of  pressurization  abnormality  in  patients  with  EoE  vs  those
without  (10  [48%]  vs  0  [0%],  p  <  0.05).
Results  from  studies  using  esophageal  manometry  to  eval-
uate  potential  motility  disorders  in  EoE  have  been  widely
variable.  In  the  absence  of  an  obvious  anatomic  abnormal-
ity,  manometry  can  be  helpful  in  identifying  an  additional
population  of  patients  who  have  failed  or  weak  peristal-
sis,  LES  dysfunction  or  abnormal  esophageal  pressurization.
However,  review  of  the  literature  suggests  there  is  an  addi-
tional  population  of  patients  whose  motility  disorder  will  be
missed.
Endoscopic  ultrasound
Esophageal  manometry  primarily  measures  the  circular  mus-
cular  function  of  the  esophagus.  Given  that  not  all  motility
disorders  are  discovered  by  this  method,  endoscopic  ultra-
sound  has  emerged  as  a  way  to  evaluate  the  longitudinal
muscle.
Korsapati  et  al.  correlated  ﬁndings  of  manometry  and
esophageal  ultrasound,  demonstrating  that  patients  with
EoE  had  changes  in  the  function  of  the  longitudinal  muscle.40
In  the  absence  of  abnormal  circular  muscle  function  wit-
nessed  on  manometry,  a  decrease  in  longitudinal  contraction
d
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mplitude  and  duration  as  well  as  dissociation  between  cir-
ular  and  longitudinal  muscle  contractions  was  observed.40
n  addition,  the  authors  used  edrophonium  to  inhibit  acetyl-
holine  breakdown  to  increase  the  level  of  acetylcholine
t  the  neuromuscular  junction.  Control  patients  were  able
o  increase  circular  and  longitudinal  muscle  contractions,
hereas  patients  with  EoE  were  not,  even  in  those  with
ormal  baseline  circular  muscle  function.  While  the  sample
ize  was  ultimately  too  small  to  draw  clinically  signiﬁcant
onclusions,  this  study  raised  questions  about  an  additional
otential  mechanism  for  muscular  motor  dysfunction.
The  use  of  endoscopic  ultrasound  has  led  to  a  proposed
echanism  that  would  help  account  for  patients  with  symp-
oms  of  dysphagia  and  food  impaction  where  other  tools  such
s  conventional  manometry  have  failed  to  identify  an  etiol-
gy.  Larger  studies  need  to  be  done  to  further  evaluate  the
elationship  between  this  proposed  physiologic  mechanism
nd  its  relation  to  the  pathophysiology  of  EoE  so  that  corre-
ations  can  be  drawn  in  relation  to  the  clinical  symptoms  of
he  disease.
ffect  of  treatment  on  esophageal  motility
bnormalities
everal  treatment  options  are  available  with  varying  efﬁ-
acy  for  the  management  of  EoE.  However,  limited  data  is
vailable  on  the  effect  of  these  treatments  on  esophageal
ysmotility.  Lucendo  et  al.  reported  an  increase  in  the
ercentage  of  normal  peristaltic  waves  (p  =  0.018)  and  a
ecrease  in  the  percentage  of  non-transmitted  waves  in
 patients  following  3  months  of  treatment  with  swallowed
uticasone  propionate  therapy  (500  g twice  daily).32 Reme-
ios  et  al.  included  19  patients  who  completed  4  weeks
f  treatment  with  swallowed  ﬂuticasone  propionate.26 All
atients  reported  dramatic  improvements  in  symptoms,
ith  complete  resolution  in  11  of  the  19  (58%)  patients.
iopsy  results  showed  a  signiﬁcant  decrease  in  eosinophilic
nﬁltration.  Unfortunately,  motility  measurements  were
nly  made  prior  to  treatment  and  it  is  unclear  if  an
mprovement  in  motility  may  have  contributed  to  symptom
mprovement.
onclusions
oE  is  an  esophageal  disorder  with  increasing  incidence  and
ecognition.  It  may  present  with  dysphagia  or  food  impaction
nd  typically  affects  younger  men.  Studies  have  shown  that
oE  is  likely  a  multifactorial  disease  triggered  by  allergens
hat  stimulate  an  immune  response  leading  to  eosinophilic
nﬁltration  of  the  esophagus.  EoE  has  been  associated  with
arying  degrees  of  esophageal  dysmotility  and  structural
bnormalities  from  ﬁbrosis  and  tissue  remodeling  that  may
ontribute  to  symptoms.  Motility  dysfunction  of  the  esoph-
gus  in  EoE  has  not  been  well  reported  in  the  literature
nd  studies  have  reported  conﬂicting  evidence  regarding
he  clinical  signiﬁcance  of  dysmotility  seen  in  EOE.  High
esolution  impedance  planimetry  testing  has  shown  reduced
istensibility,  or  compliance,  that  has  been  associated  with
he  occurrence  of  food  impaction.27 Esophageal  manometry
tudies  in  EoE  patients  have  been  few  and  included  small
atient  cohorts  or  case  reports.  The  occurrence  of  abnormal
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sophageal  manometry  was  reported  to  be  between  4%
nd  87%  among  patients  with  EoE.  Dysmotility  may  present
s  abnormal  peristalsis  or  hypotensive  LES.  Reports  have
emonstrated  that  EoE  may  mimic  other  esophageal  motility
isorders  such  as  achalasia  or  nutcracker  esophagus,  thus
aking  the  diagnosis  more  difﬁcult.  EoE  has  also  been  shown
o  have  a  similar  rate  of  motility  dysfunction,  particularly
eak  or  absent  peristalsis,  to  that  of  patients  with  GERD.38
he  inconsistencies  on  esophageal  manometry  studies  may
e  explained  by  disease  activity  at  the  time  of  the  study
r  disease  duration,  with  some  studies  indicating  a higher
requency  of  dysmotility  associated  with  longer  disease
uration.  Additionally,  it  remains  unclear  if  a  correlation
xists  between  esophageal  dysmotility  and  symptoms  of
oE.  Larger  studies  are  needed  to  investigate  the  incidence
f  esophageal  dysmotility,  clinical  implications,  and  effect
f  treatment  on  patients  with  EoE.
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